Results overview: Found 6 records in 0.02 seconds.
Articles, 2 records found
Research literature, 4 records found
Articles 2 records found  
1.
6 p, 403.0 KB Prevalence of cardiovascular risk factors in people with epilepsy / Vivanco-Hidalgo, Rosa Maria (Universitat Autònoma de Barcelona) ; Gómez González, Alejandra (Parc de Salut Mar. Departament de Neurologia) ; Moreira, Antia (Parc de Salut Mar. Departament de Neurologia) ; Díez, Laura (Parc de Salut Mar. Departament de Neurologia) ; Elosua, Roberto (Fundació Institut Mar d'Investigacions Mèdiques) ; Roquer González, Jaume (Universitat Autònoma de Barcelona)
Epilepsy has been associated with cardiovascular comorbidity. This study aimed to assess the potential association between cardiovascular risk factors (s), antiepileptic drugs (s), and etiology. A single‐center retrospective epilepsy cohort from the decade of 2004–2013 was assessed. [...]
2017 - 10.1002/brb3.618
Brain and behavior, Vol. 7, issue 2 (Feb. 2017)  
2.
11 p, 168.8 KB Genetic variants in CETP increase risk of intracerebral hemorrhage / Anderson, Christopher D. (Program in Medical and Population Genetics, Broad Institute) ; Falcone, Guido J. (Departments of Epidemiology and Biostatistics, Harvard T. H. Chan School of Public Health) ; Phuah, Chia‐Ling (Program in Medical and Population Genetics, Broad Institute) ; Radmanesh, Farid (Program in Medical and Population Genetics, Broad Institute) ; Brouwers, H. Bart (Program in Medical and Population Genetics, Broad Institute) ; Battey, Thomas W. K. (Program in Medical and Population Genetics, Broad Institute) ; Biffi, Alessandro (Division of Psychiatry, Department of Psychiatry, MGH) ; Peloso, Gina M. (Program in Medical and Population Genetics, Broad Institute) ; Liu, Dajiang J. (Institute of Personalized Medicine, Penn State College of Medicine) ; Ayres, Alison M. (J. Philip Kistler Stroke Research Center, Department of Neurology, MGH) ; Goldstein, Joshua N. (Department of Emergency Medicine, MGH) ; Viswanathan, Anand (J. Philip Kistler Stroke Research Center, Department of Neurology, MGH) ; Greenberg, Steven M. (J. Philip Kistler Stroke Research Center, Department of Neurology, MGH) ; Selim, Magdy (Beth Israel Deaconess Medical Center) ; Meschia, James F. (Mayo Clinic) ; Brown, Devin L. (University of Michigan Health System) ; Worrall, Bradford B. (University of Virginia Health System) ; Silliman, Scott L. (University of Florida College of Medicine) ; Tirschwell, David L. (University of Washington) ; Flaherty, Matthew L. (University of Cincinnati College of Medicine) ; Kraft, Peter (Departments of Epidemiology and Biostatistics, Harvard T. H. Chan School of Public Health) ; Jagiella, Jeremiasz M. (Jagiellonian University Medical College) ; Schmidt, Helena (Medical University Graz) ; Hansen, Björn M. (Skåne University Hospital) ; Jimenez‐Conde, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Giralt‐Steinhauer, Eva (Institut Hospital del Mar d'Investigacions Mèdiques) ; Elosua Llanos, Roberto (Institut Hospital del Mar d'Investigacions Mèdiques) ; Cuadrado‐Godia, Elisa (Institut Hospital del Mar d'Investigacions Mèdiques) ; Soriano Tàrraga, Carolina (Institut Hospital del Mar d'Investigacions Mèdiques) ; van Nieuwenhuizen, Koen M. (University Medical Center Utrecht) ; Klijn, Catharina J. M. (Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center) ; Rannikmae, Kristiina (University of Edinburgh) ; Samarasekera, Neshika (University of Edinburgh) ; Salman, Rustam Al‐Shahi (University of Edinburgh) ; Sudlow, Catherine L. (University of Edinburgh) ; Deary, Ian J. (University of Edinburgh) ; Morotti, Andrea (Neurology Clinic, University of Brescia) ; Pezzini, Alessandro (Neurology Clinic, University of Brescia) ; Pera, Joanna (Jagiellonian University Medical College) ; Urbanik, Andrzej (Jagiellonian University Medical College) ; Pichler, Alexander (Medical University of Graz) ; Enzinger, Christian (Medical University of Graz) ; Norrving, Bo (Skåne University Hospital) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernandez‐Cadenas, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Delgado Martínez, Pilar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Roquer González, Jaume (Institut Hospital del Mar d'Investigacions Mèdiques) ; Lindgren, Arne (Skåne University Hospital) ; Slowik, Agnieszka (Jagiellonian University Medical College) ; Schmidt, Reinhold (Medical University of Graz) ; Kidwell, Chelsea S. (University of Arizona) ; Kittner, Steven J. (Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine) ; Waddy, Salina P. (National Institutes of Health) ; Langefeld, Carl D. (Wake Forest University) ; Abecasis, Goncalo (University of Michigan School of Public Health) ; Willer, Cristen J. (University of Michigan Medical School) ; Kathiresan, Sekar (Cardiovascular Disease Prevention Center, MGH) ; Woo, Daniel (University of Cincinnati College of Medicine) ; Rosand, Jonathan (Program in Medical and Population Genetics, Broad Institute) ; Universitat Autònoma de Barcelona. Departament de Neurologia
In observational epidemiologic studies, higher plasma high‐density lipoprotein cholesterol (HDL‐C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL‐C; as such, medicines that inhibit CETP and raise HDL‐C are in clinical development. [...]
2016 - 10.1002/ana.24780
Annals of Neurology, Vol. 80 (october 2016) , p. 730-740  

Research literature 4 records found  
1.
67 p, 576.6 KB Factors de risc i risc cardiovascular en els pacients amb epilèpsia / Vivanco Hidalgo, Rosa Maria, autor. ; Roquer González, Jaume, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
L'epilèpsia s'ha associat a la malaltia cardiovascular (CV). El diagnòstic i control dels factors de risc cardiovascular (FRCV) junt amb les equacions per predir el risc es consideren l'abordatge principal en la prevenció primària CV. [...]
Epilepsy has been associated with cardiovascular (CV) comorbidity. The diagnosis and control of cardiovascular risk factors (CVRF) as well as the use of risk prediction equations are considered the standard approach in primary prevention of cardiovascular disease. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
2.
118 p, 6.0 MB Influencia de los hábitos dietéticos y de la obesidad abdominal en el ictus isquémico / Rodríguez Campello, Ana, autor ; Roquer González, Jaume, supervisor acadèmic ; Goday Arno, Albert, supervisor acadèmic ; Universitat Autònoma de Barcelona. Departament de Medicina
Objetivos: Analizar si existen diferencias dietéticas y antropométricas entre pacientes con ictus isquémico y controles de una misma población y evaluar si existen diferencias por género y subtipos de ictus. [...]
Objectives: To analyze if there are dietary and anthropometric differences between patients with ischemic stroke and controls of the same population and to evaluate if there are differences by gender and stroke subtypes. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017  
3.
136 p, 2.2 MB Evolució inicial dels ictus per arteriosclerosi carotídia. Severitat, deteriorament neurològic i recurrència / Cuadrado Godia, Elisa ; Roquer González, Jaume, dir. ; Cladellas Capdevila, Mercè ; Universitat Autònoma de Barcelona. Departament de Medicina
L'arteriosclerosi és la principal causa de mortalitat avui en dia a nivell mundial. Dintre de les seves manifestacions clíniques, aquesta tesi s'ha centrat en l'estudi dels ictus per arteriosclerosi carotídia (AC) , una causa molt freqüent d'ictus a la nostra població. [...]
Atherosclerosis is the leading cause of death worldwide. This thesis focuses on one of its clinical manifestations, the strokes due to carotid atherosclerosis (CA). This is one of the most frequent sources of stroke in our population and carries a high risk of recurrence. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
4.
239 p, 1.0 MB Comparativa de niveles plasmáticos, implicaciones clínicas y costes entre pacientes tratados con valproico endovenoso genérico frente a pacientes tratados con valproico endovenoso innovador / Marín Casino, Mónica ; Mur Sierra, Antonio, dir. ; Roquer González, Jaume, dir. ; Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva
Con el objetivo de contener el gasto farmacéutico, una de las recomendaciones de las Administraciones Sanitarias es la utilización de fármacos genéricos. Su principal ventaja es un menor coste, debido al ahorro en investigación. [...]
In order to maximize cost savings, health care systems recommend the use of generic drugs. Its main advantage is lower cost, due to savings in research. However, small variations in bioavailability among generic drugs and brand-name drugs in epilepsy may be associated with negative effects with significant clinical changes (loss of seizure control, loss of jobs / driving license). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.